Invasive breast cancer is a major cause of death in women, especially those living in developed countries [1] . 
Introduction
Invasive breast cancer is a major cause of death in women, especially those living in developed countries [1] . The majority of invasive breast carcinoma is of ductal type, comprising up to 80% of all cases. Among the unfavourable prognostic predictors, auxiliary nodal status is the most significant, as positive status of nodes dramatically decrease survival rate [2] [3] [4] [5] , and result in loss of cell polarity, acquisition of migratory phenotype and breakdown of the basement membrane. Multiple factors, including hormonal signalling, cytokine signalling, altered cell-matrix interactions and subsequent intracellular signalling, play a role in this process [6, 7] . [8] . ER [10] [11] [12] and by their proliferative and growth inhibitory effects in different breast cancer cell lines [13, 14] . Approximately 70% to 90% of primary breast cancers express AR, suggesting that AR may modulate tumorigenesis [11, 12, 15] . The in vitro studies of androgen effect on breast cancer using established cell lines provided controversial results [16] . [17] [18] [19] . Further, the growth regulatory function of AR is different in the breasts of pre-menopausal and postmenopausal women [13, 20] . Androgens function through binding to androgen receptor (AR) and initiating AR-associated intracellular signalling pathways [21] . Initial binding of androgen to AR and augmentation of AR activity by its coactivator(s) are two critical steps in the AR-mediated pathway [22, 23] . There are a number of tumorigenic mechanisms in breast cancer involving alteration of the AR pathway. Alteration of AR protein structure could be associated with breast cancer [16] . Germ line mutation resulting in androgen insensitivity appears to be associated with an increased risk of male breast cancer development [24, 25] . An exon 3 deletion splice variant has been identified in three human breast cancer cells lines [26] [27] .
. Tumorigenesis is a multistep process, starting from transformation of benign epithelial cells to dysplastic and neoplastic cells, leading to invasion and metastasis. Prior to invasion and metastasis, malignant epithelial cells undergo a process referred to as epithelial-mesenchymal transition

It has been well known that oestrogen and oestrogen receptor (ER)-associated signalling cascades are the important mediators of the development of carcinoma of breast
Androgens inhibit the growth of T-47D, ZR-75-1 and MFM-223 cells at certain concentrations, while promotion of the growth of MCF-7 and EFM-19 cells have also been reported
p44 is a recently identified AR interacting protein [28] . p44 exhibits a salt-sensitive high affinity binding to AR, and enhances AR driven transcriptional activation. We have previously reported that p44 is expressed as a nuclear protein in benign prostate epithelia and translocates to the cytoplasm in prostate cancer cells [29, 30] . Similar observations are made in benign and malignant testicular cells [31] . Moreover, we show that the nuclear expression of p44 inhibits prostate cancer cell growth both in vitro and in vivo [29, 30] (Fig. 3B, lanes 1-3) . To confirm correct localization of exogenous p44, western blot analysis was performed with cytoplasmic and nuclear extract from MCF7 cells overexpressing NLSp44 and NESp44. MCF7 overexpressing NESp44 cells showed that both exogenous and endogenous p44 were restricted to the cytoplasm (Fig. 3C, lane 3) , while MCF7 cells overexpressing NLSp44 resulted in cytoplasmic and nuclear localization of p44 (Fig. 3C, lanes 5 and 6) . The nuclear localization of NLSp44 (Fig. 3D ) and cytoplasmic localization of NESp44 (Fig. 3E ) was confirmed by immunofluorescent microscopy using EGFP fusion proteins to NLSp44 (EGFP-NLSp44) and NESp44 (EGFP-NESp44) [30] . For MCF7 cells with pBabe control vector, p44 was seen in the cytoplasm but not present in the nuclear fraction since p44 was expressed as nuclear protein in only 25% of MCF7 cells (Fig. 1D, arrows) . (Fig. 4C) or absence (Fig. 4D) (Fig. S1F) as well as increased promoter occupancy of p44 onto the MYC promoter (Fig. 4H) . (Fig. 5B and C) (Fig. 5C ) in oestrogen media. (Fig. 5C) . The ER␣ knockdown did not affect the invasion ability of MCF7-pBabe cells (Fig. 5C) . (Fig. 5D) . Thus, the increased invasion ability is not due to increased cell migration. [9] . Androgen, AR and coactivators have been implicated to play a part in breast oncogenesis [15] . A number of coactivators act on both androgen and oestrogen pathways, and possibly mediate the interplay between the two receptors. Coactivator ARA70 can interact with both AR and ER increasing the receptor-mediated transcriptional activities [27] . Dysregulation of ARA70 expression is indicated in cancer development in both breast and prostate cancer [35, 36] . In this study, we show p44 can also function as ER coactivator to activate the ER target gene expression.
Materials and methods
Breast cancer specimen
Matrigel invasion and migration assays
Results
Expression of p44 in benign and malignant breast cells
We examined the expression profile of p44 in benign and malignant breast ductal cells by immunohistochemical studies (IHC
Oestrogen-mediated cell proliferation by nuclear p44 in MCF7 breast cancer cells
of oestrogen. To further determine the effects of ER␣ on the oestrogendependent nuclear p44 mediated cell proliferation, we performed ER␣ knockdown with siRNA followed by growth kinetic experiments. There is a reduced rate of cell growth with ER␣ knockdown even in the presence of oestrogen (Fig. 4E). Together with the data that the nuclear p44 only stimulated cell growth in MCF7 (ER ϩ ), but not MDA-MB-231 (ER -) cells, there is a strong indication that the nuclear p44 promoted cell proliferation is ER␣ dependent. We also examined cell cycle gene expression to determine affected pathways involved in nuclear p44 mediated growth promotion by Western blot analysis including p21, p27, cyclin A2, cyclin B1, cyclin D1 and cyclin E. The results revealed increased expression of cyclinB1 (Fig. S1A) when nuclear p44 was overexpressed in MCF7 cells in the presence of oestrogen while the levels of other cyclins remained unchanged (Fig. S1E). The levels of cyclin B1 did not change in MCF7-NLSp44 cells (Fig. S1B). The level of cyclin B1 also did not change in MDA-MB-231 cells in both hormone free
Fig. 1 Expression of p44 in benign and malignant breast tissue, Immunohistochemistry showed cytoplasmic expression of p44 in benign breast epithelium (A). Nuclear p44 is observed in DCIS (B) and invasive ductal carcinoma (C). Nuclear p44 is expressed in 25% of MCF7 cells (D). (Magnification: A-D: 400ϫ). and androgen media (Fig. S1C and D), indicating the growth inhibition by nuclear p44 in MDA-MB-231 cells is not through decrease in cyclin B1. The levels of p21 and p27 were not changed (data not shown). To determine the mechanisms of the p44 enhanced cell growth by oestrogen, we examined p44 nuclear cytoplasmic shuttling by fluorescent microscopy using GFP-p44, as well as promoter occupancy and expression of ER target gene MYC by nuclear p44. P44 was expressed as cytoplasmic protein (25% cells with nuclear p44 expression) under hormone free condition (Fig. 4F upper panel) and as nuclear protein (85% cells with nuclear p44 expression) in the presence of 10 nM 17-␤-estradiol (Fig. 4F lower panel). In contrast to MCF7 cells, p44 was localized in both nuclear and cytoplasm of MDA-MD-231 cells. Oestrogen did not affect p44 nuclear localization of MDA-MD-231cells. We further determined expression of ER target gene MYC using RT-PCR with nuclear p44 overexpression (MCF7-NLSp44 cells) and promoter recruitment of p44 onto MYC promoter using a ChIP analysis. The results of the experiments showed increased MYC expression by RT-PCR (Fig. 4G) and real time qRT-PCR
Nuclear p44 may promote MCF7 breast cancer cell invasion by in vitro Matrigel assays
. The increased invasion ability was observed in neither hormone free nor androgen media (data not shown). In contrast, NESp44 inhibited invasion up to 2-fold
Fig. 2 p44 enhances AR and ER mediated transcriptional activation, p44 increased the levels of ER mediated transcriptional activation up to 2-fold (A) and increased the levels of AR mediated transcriptional activation up to 2.5-fold (B) in MCF7 cells in dual luciferase assays. In luciferase assays, the concentration of reagents where appropriate is as follow: androgen (10 nM R1881), oestrogen (10 nM 17-␤-estradiol), AR (30 ng), ER (30 ng) and p44 (100 ng, 200 ng, 300 ng and 600 ng).
Fig. 3 Stable cell lines expressing nuclear and cytoplasmic p44, Clonal and pooled cell lines expressing NLSp44 and NESp44 were established. Western blot analysis of whole cell lysate showed expression of NESp44 (A, lane 2, upper band) and NLSp44 (A, lane 3, upper band). ␤-actin was used as loading control (B, lanes 1-3). Nuclear and cytoplasmic fraction showed cytoplasmic expression of NESp44 (C, lane 3) and nuclear expression of NLSp44 (C, lane 6 versus lane 5). Nuclear expression of EGFP-NLSp44 in MCF7 cells (D). Cytoplasmic expression of EGFPNESp44 in MCF7 cells (E)
.
To further determine whether increased breast cancer cell invasion ability by nuclear p44 is dependent on ER, we used siRNA to knockdown ER␣ followed by Matrigel invasion assays. The results showed more than 2-fold decrease in the number of invasive cells for MCF7-NLSp44 cells in the presence of oestrogen
To determine whether the increased invasive ability of MCF7-NLSp44 cells was due to increased cell migration ability, we performed wound healing assays with MCF7-NLSp44 cells in the presence of oestrogen. Cells were seeded evenly and a linear wound was introduced. The results indicated that the distance that MCF7-NLSp44 cells migrated towards the wound area is at a comparable level to the control MCF7-pBabe cells
Fig. 5 Nuclear p44 promotes MCF7 breast cancer cell invasion through oestrogen pathway, Matrigel invasion assays showed, compared to pBabe control (A), increased invasive cells by NLSp44 (B), up to 4-fold in MCF7 cells. NESp44 moderately decreased invasion ability of MCF7 cells (C). NLSp44 did not alter migration ability of MCF7 cells (D).
Cells pBabe NLSp44 NESp44
Ki 67 (%) 87 Ϯ 2 91 Ϯ 1 79 Ϯ 1 
